Skip to content

ENDONOVO THERAPEUTICS, INC.: filings

Every ENDONOVO THERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 47 filings, each linked to its SEC index.

Filing record ends 2023-12-29

The latest filing in this captured record is a 10-Q/A filed 2023-12-29. No later filing is in the SEC companyfacts record captured on 2026-09-20. ENDONOVO THERAPEUTICS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q/A2023-12-29fiscal Q3 202332990001493152-23-046561
10-Q2023-12-29fiscal Q3 202332990001493152-23-046444
10-Q2023-08-21fiscal Q2 202332950001493152-23-029706
10-Q2023-05-22fiscal Q1 202333620001493152-23-018538
10-K2023-04-17fiscal FY 202231590001493152-23-012553
10-Q2022-11-21fiscal Q3 202232900001493152-22-033118
10-Q2022-08-22fiscal Q2 202234930001493152-22-023661
10-Q2022-05-19fiscal Q1 202233640001493152-22-014380
10-K2022-04-14fiscal FY 202138710001493152-22-009861
10-Q2021-11-19fiscal Q3 2021411130001493152-21-029295
10-Q2021-08-23fiscal Q2 2021401060001493152-21-020979
10-Q2021-05-24fiscal Q1 202138740001493152-21-012695
10-K2021-04-13fiscal FY 202039750001493152-21-008661
10-Q2020-11-19fiscal Q3 2020421150001493152-20-022038
10-Q2020-08-19fiscal Q2 2020411070001493152-20-016283
10-Q2020-06-12fiscal Q1 202038750001493152-20-011037
10-K2020-05-04fiscal FY 201936710001493152-20-007577
10-Q2019-11-19fiscal Q3 201934930001493152-19-017990
10-Q2019-08-13fiscal Q2 201935890001493152-19-012155
10-Q2019-05-09fiscal Q1 201935680001493152-19-006636
10-K2019-04-15fiscal FY 201836660001493152-19-005267
10-Q2018-11-13fiscal Q3 201834750001493152-18-015639
10-Q2018-08-13fiscal Q2 201839920001493152-18-011549
10-Q2018-05-18fiscal Q1 201831580001493152-18-007419
10-K2018-04-06fiscal FY 201727530001493152-18-004879
10-Q/A2017-11-09fiscal Q3 201724570001493152-17-012663
10-Q2017-11-07fiscal Q3 201724570001493152-17-012539
10-Q2017-08-10fiscal Q2 201728720001493152-17-008874
10-Q2017-05-12fiscal Q1 201723470001493152-17-005116
10-K2017-04-17fiscal FY 201627510001493152-17-003917
10-Q2016-11-14fiscal Q3 201624560001493152-16-014851
10-Q2016-08-12fiscal Q2 201623540001493152-16-012245
10-Q2016-05-27fiscal Q1 201624500001469709-16-000843
10-K2016-05-17fiscal FY 201525530001469709-16-000821
10-K2016-04-05fiscal FY 201525530001469709-16-000755
10-Q2015-11-23fiscal Q3 201523600001469709-15-000627
10-Q2015-08-19fiscal Q2 201524610001469709-15-000490
10-Q2015-06-15fiscal Q1 201523490001213900-15-004468
10-K2015-06-15fiscal FY 201425460001213900-15-004466
10-Q2013-12-18fiscal Q3 201323610001469709-13-000717
10-Q/A2013-08-28fiscal Q2 201322590001469709-13-000514
10-Q/A2013-06-21fiscal Q1 201321460001469709-13-000402
10-K/A2013-05-03fiscal FY 201223470001469709-13-000288
10-Q2012-11-29fiscal Q3 201221370001469709-12-000341
10-Q2012-08-20fiscal Q2 201221370001469709-12-000212
10-Q2012-05-21fiscal Q1 201221450001469709-12-000113
10-K2012-04-13fiscal FY 201125520001469709-12-000077

Inspect the source

Entity
ENDONOVO THERAPEUTICS, INC. / CIK 0001528172
Captured
2026-09-20T09:15:36.026Z
SEC response SHA-256
77af3f2eba134146bbd094e17b18f0fd658f8dd873b389b6434b1de9b2ac5f8a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001528172.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))